Cresco Labs (CRLBF) Current Leases (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Current Leases came in at $10.3 million in Q1 2026, up 5.16% on a QoQ basis from $9.8 million in Q4 2025.

Cresco Labs (CRLBF) Current Leases (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Current Leases data on file, last reported at $10.3 million in Q1 2026.

Quarterly Current Leases changed N/A year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (changed N/A YoY) and the FY2025 annual result came in at $9.8 million, changed N/A from the prior year.
Current Leases grew to $10.3 million in Q1 2026, from $9.8 million in the prior quarter.
In the past five years, Current Leases ranged from a high of $21.1 million in Q1 2022 to a low of $1.7 million in Q4 2023.
A 5-year average of $10.5 million and a median of $10.2 million in 2024 frame the typical range for Current Leases.
Annual changes were most pronounced in 2022 — Current Leases surged 37.08% — and 2023, when it plunged 80.59%.
Tracing CRLBF's Current Leases over 5 years: stood at $9.0 million in 2022, then sank by 80.59% to $1.7 million in 2023, then soared by 542.27% to $11.2 million in 2024, then slipped by 12.32% to $9.8 million in 2025, then gained by 5.16% to $10.3 million in 2026.
The last three Current Leases figures came in at $10.3 million (Q1 2026), $9.8 million (Q4 2025), and $11.2 million (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Cresco Labs	295.09 Mn	230.98 Mn	86.95 Mn	11.69 Mn

Download Data